COLLPLANT BIOTECH. IS-01 (CPT) — Capital Reinvestment Ratio
Latest as of December 2021:
0.64x
COLLPLANT BIOTECH. IS-01 (CPT) has a Capital Reinvestment Ratio of 0.64x as of December 2021, meaning it reinvests 1% of its operating cash flow (€2.50 Million) in capital expenditures (€1.59 Million). See COLLPLANT BIOTECH. IS-01 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.64x
Capex / Operating Cash Flow
Operating Cash Flow
€2.50 Million
EUR
Capital Expenditures
€1.59 Million
EUR
Data as of
Dec 2021
Most recent filing
COLLPLANT BIOTECH. IS-01 Capital Reinvestment Ratio (2021–2021)
This chart tracks COLLPLANT BIOTECH. IS-01's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for COLLPLANT BIOTECH. IS-01 (2021–2021)
Year-by-year Capital Reinvestment Ratio for COLLPLANT BIOTECH. IS-01 from 2021 to 2021. For live market cap and broader valuation context, see CPT market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.64x | €2.50 Million | €1.59 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow